Shahram Salek-ardakani - Net Worth and Insider Trading
Shahram Salek-ardakani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shahram Salek-ardakani owns 1 companies in total, including Janux Therapeutics Inc (JANX) .
Click here to see the complete history of Shahram Salek-ardakani’s form 4 insider trades.
Insider Ownership Summary of Shahram Salek-ardakani
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2021-07-12 | Chief Scientific Officer |
Shahram Salek-ardakani Trading Performance
Shahram Salek-ardakani Ownership Network
Shahram Salek-ardakani Owned Company Details
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Shahram Salek-ardakani is the Chief Scientific Officer of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include 10 percent owner Avalon Ventures Xi, L.p. , director & 10 percent owner Jay Lichter , and 10 percent owner & Acting Chief Financial Officer Tighe Reardon .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Shahram Salek-ardakani made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 1,343,419 shares made by Avalon Ventures Xi, L.p. , a net sale of 650,146 shares made by Jay Lichter , and a net purchase of 27,133 shares made by Tighe Reardon .
In summary, during the past 3 months, insiders sold 693,273 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 693,273 shares. During the past 18 months, 4,515,994 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net sale of 1,471,424 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
Shahram Salek-ardakani Mailing Address
Above is the net worth, insider trading, and ownership report for Shahram Salek-ardakani. You might contact Shahram Salek-ardakani via mailing address: C/o Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
